|
HOOK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62049999996583E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.323340E-03 |
| Normal-vs-Stage2 |
1.894840E-01 |
| Normal-vs-Stage3 |
5.636400E-02 |
| Normal-vs-Stage4 |
1.358220E-01 |
| Stage1-vs-Stage2 |
8.960000E-01 |
| Stage1-vs-Stage3 |
2.195400E-01 |
| Stage1-vs-Stage4 |
7.932000E-01 |
| Stage2-vs-Stage3 |
5.014600E-01 |
| Stage2-vs-Stage4 |
7.856600E-01 |
| Stage3-vs-Stage4 |
5.407200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.9294000000023E-05 |
| Normal-vs-AfricanAmerican |
1.967640E-02 |
| Normal-vs-Asian |
7.975200E-01 |
| Caucasian-vs-AfricanAmerican |
5.599600E-01 |
| Caucasian-vs-Asian |
6.934100E-02 |
| AfricanAmerican-vs-Asian |
3.704800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.840500E-04 |
| Normal-vs-Female |
2.963400E-04 |
| Male-vs-Female |
9.355800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.998500E-03 |
| Normal-vs-Extreme_Weight |
3.188200E-02 |
| Normal-vs-Obese |
2.743100E-03 |
| Normal-vs-Extreme_Obese |
2.616600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.860000E-01 |
| Normal_Weight-vs-Obese |
3.542000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.501200E-01 |
| Extreme_Weight-vs-Obese |
4.976600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.452400E-01 |
| Obese-vs-Extreme_Obese |
2.141600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.120100E-02 |
| Normal-vs-Age(41-60Yrs) |
7.68960000000485E-05 |
| Normal-vs-Age(61-80Yrs) |
6.622500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.611000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.663600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.211200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.261800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.742400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.079800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.434240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.29859999997706E-06 |
| Normal-VS-Type2 PRCC |
6.203700E-02 |
| Normal-VS-KIRP CIMP |
3.215800E-01 |
| Normal-VS-Unclassified PRCC |
8.409900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.677580E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.853500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.829810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.580200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.200200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.286200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.157380E-01 |
| Normal-vs-N1 |
7.922200E-02 |
| Normal-vs-N2 |
2.733200E-01 |
| N0-vs-N1 |
2.308600E-01 |
| N0-vs-N2 |
1.889780E-01 |
| N1-vs-N2 |
8.990400E-01 |
|
|
